SCHEMBL8435135

SCHEMBL8435135

CC[C@H]1CN(Cc2ccccc2)C[C@H]1NC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
NPFFR1 Q9GZQ6 1/20 0.43
NPFFR2 Q9Y5X5 1/20 0.43
DRD2 P14416 4/20 0.42
DRD4 P21917 4/20 0.42
DRD3 P35462 4/20 0.42
MAOB P27338 2/20 0.41
KDM1A O60341 1/20 0.41
KCNA3 P22001 1/20 0.41
JAK1 P23458 1/20 0.41
BCHE P06276 3/20 0.40
S1PR1 P21453 1/20 0.40
S1PR5 Q9H228 1/20 0.40
EPHX2 P34913 1/20 0.40
ACHE P22303 1/20 0.40
MEN1 O00255 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA7 P43166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20848126 1.00 KMT2A (0.52) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL8564168 1.00 KMT2A (0.52) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL19083304 0.91 KMT2A (0.52) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL19063785 0.91 KMT2A (0.52) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL19098262 0.91 KMT2A (0.52) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL19123095 0.91 KMT2A (0.52) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL7804232 0.91 KMT2A (0.52) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL21684765 0.90 KMT2A (0.51) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL20722866 0.90 KMT2A (0.51) KMT2AL3MBTL1NPFFR1NPFFR2DRD2
SCHEMBL376613 0.90 KMT2A (0.51) KMT2AL3MBTL1NPFFR1NPFFR2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113631557-B JAK kinase inhibitor, preparation method thereof and application thereof in medicine field 上海华汇拓医药科技有限公司 2024-03-15 CN disclosed
CN-109535164-B JAK kinase inhibitor, preparation method thereof and application thereof in medical field 上海华汇拓医药科技有限公司 2022-01-18 CN disclosed
CN-113631557-A JAK kinase inhibitor, preparation method thereof and application thereof in medical field 上海华汇拓医药科技有限公司 2021-11-09 CN disclosed
WO-2019057103-A1 JAK INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION IN THE FIELD OF MEDICINE 上海华汇拓医药科技有限公司 2019-03-28 WO disclosed
US-5859026-A ADMINISTERING AS AN ANTIBACTERIAL AGENT HOKURIKU SEIYAKU CO., LTD. (JP) 1999-01-12 US disclosed
US-5837868-A REACTION OF DIHYDROXY OLEFINS IN A MULTISTAGE PROCESS ARYL METHYLAMINE TO FORM PYRROLIDINE INTERMEDIATE ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5703244-A CYCLIZATION OF DIHYDROXY OLEFINS WITH TARTRATE ESTER IN PRESENCE OF TITANIUM ISOPROPOXIDE AND TERT-BUTYL HYDROPEROXIDE ABBOTT LABORATORIES (US) 1997-12-30 US disclosed